These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Evaluation and treatment of disorders of the coronary circulation]. HOCHREIN M Dtsch Med J; 1952 Sep; 3(17-18):390-7. PubMed ID: 13020640 [No Abstract] [Full Text] [Related]
24. [First results with nialamide in cardiovascular therapy]. SCOPPOLA L; GANDINI L Minerva Med; 1959 Dec; 50():4442-7. PubMed ID: 14444188 [No Abstract] [Full Text] [Related]
25. Treatment of myocardial infarction due to coronary thrombosis; a preliminary report. McCOLLUM WT J Okla State Med Assoc; 1952 Jan; 45(1):15-9. PubMed ID: 14898340 [No Abstract] [Full Text] [Related]
26. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7: the era of reperfusion: section 1: acute coronary syndromes (acute myocardial infarction). The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation; 2000 Aug; 102(8 Suppl):I172-203. PubMed ID: 10966673 [No Abstract] [Full Text] [Related]
28. Optimal resources for the care of patients with acute myocardial infarction and chronic coronary heart disease. Coronary Heart Disease Study Group. Yu PN; Conti CR; Jones P; Humphries JO; Rackley CE; Resnekov L; Schlant RC Circulation; 1982 Mar; 65(3):654B-667B. PubMed ID: 6276044 [No Abstract] [Full Text] [Related]
29. Clinical evaluation of miradon. KELLAWAY G Br Med J; 1958 Oct; 2(5101):889-91. PubMed ID: 13572936 [No Abstract] [Full Text] [Related]
30. [Myocardial infarct and acute coronary syndrome. New research results or acute treatment and secondary prevention]. von Susanne Heinzl B Med Monatsschr Pharm; 2001 Nov; 24(11):374-8. PubMed ID: 11727300 [No Abstract] [Full Text] [Related]
31. [Studies with a derivative of the pyrimido-pyrimidines, "RA 8"]. BURGOS DE PABLO A Rev Esp Cardiol; 1961 Oct; 14():758-805. PubMed ID: 13874849 [No Abstract] [Full Text] [Related]
32. [2 hours for saving a heart]. Beaufils P Rev Infirm; 1990 Feb; 40(4):36-8. PubMed ID: 2089579 [No Abstract] [Full Text] [Related]
33. Diagnosable coronary heart disease. III. Unusual aspects or complications of myocardial infarction. SHALLARD B Northwest Med; 1956 Jan; 55(1):63-4. PubMed ID: 13280166 [No Abstract] [Full Text] [Related]
34. Effects of chronic warfarin therapy on complications of coronary angioplasty during acute myocardial infarction. Kahn JK; Kodali U; Savas V; Gordon R Am J Cardiol; 1995 Apr; 75(10):724. PubMed ID: 7900670 [No Abstract] [Full Text] [Related]
35. Coronary heart disease. Its medical management and treatment in 1965. Brock JF S Afr Med J; 1965 Oct; 39(37):835-41. PubMed ID: 5852958 [No Abstract] [Full Text] [Related]
36. The production of myocardial infarction, chronic coronary insufficiency and chronic coronary heart disease in the dog. MARCUS E; KATZ LN; PICK R; STAMLER J Acta Cardiol; 1958; 13(2):190-8. PubMed ID: 13532285 [No Abstract] [Full Text] [Related]
38. Papaverine suppositories in myocardial infarction. LUSTOK MJ Wis Med J; 1952 Mar; 51(3):275. PubMed ID: 14913968 [No Abstract] [Full Text] [Related]
39. [Heart infarct in The Netherlands; decreased mortality, increased morbidity and more intervention]. Dunning AJ Ned Tijdschr Geneeskd; 1990 Mar; 134(12):573-4. PubMed ID: 2320156 [No Abstract] [Full Text] [Related]
40. [Comparison of drug therapy and PTCA in coronary heart disease]. vom Dahl J Internist (Berl); 1994 May; 35(5):496-8. PubMed ID: 8021120 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]